Proneural-mesenchymal transformation of glioma stem cells: Do therapies cause evolution of target in glioblastoma?

Future Oncology

Volumn 10, Issue 9, 2014, Pages 1527-1530

  Nakano, Ichiro ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

brain tumor; competition; cooperation; GBM; glioblastoma; glioma stem cells

Indexed keywords

CANCER STEM CELL; CANCER THERAPY; CELL TRANSFORMATION; EVOLUTION; GLIOBLASTOMA; HUMAN; INFLAMMATION; MESENCHYMAL STEM CELL; NERVE CELL PLASTICITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BRAIN NEOPLASMS; CELL TRANSDIFFERENTIATION; DRUG EFFECTS; PATHOLOGY; PHYSIOLOGY;

ANTINEOPLASTIC AGENT;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL TRANSDIFFERENTIATION; GLIOBLASTOMA; HUMANS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION;

EID: 84906571689     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.14.86     Document Type: Review

References (20)

1. Phillips HS, Kharbanda S, Chen R et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9(3), 157-173 (2006
2. Verhaak RG, Hoadley KA, Purdom E et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1), 98-110 (2010
3. Bhat KP, Balasubramaniyan V, Vaillant B et al. Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma Cancer Cell 24(3), 331-346 (2013
4. Mao P, Joshi K, Li J et al. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc. Natl Acad. Sci. USA 110(21), 8644-8649 (2013
5. American Cancer Society. www.cancer.org
6. Locatelli M, Ferrero S, Martinelli Boneschi F et al. The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas. J. Neuroimmunol. 260(1-2), 99-106 (2013
7. Oh MC, Kim JM, Safaee M et al. Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells. PLoS ONE 7(10), e47846 (2012
8. Singh SK, Hawkins C, Clarke ID et al. Identification of human brain tumour initiating cells. Nature 432(7015), 396-401 (2004
9. Beier D, Schulz JB, Beier CP. Chemoresistance of glioblastoma cancer stem cells-much more complex than expected. Mol. Cancer 10, 128 (2011
10. Miyazaki T, Pan Y, Joshi K et al. Telomestatin impairs glioma stem cell survival and growth through the disruption of telomeric G-quadruplex and inhibition of the proto-oncogene, c-Myb. Clin. Cancer Res. 18(5), 1268-1280 (2012
11. Albazaz R, Verbeke CS, Rahman SH, McMahon MJ. Cyclooxygenase-2 expression associated with severity of PanIN lesions: a possible link between chronic pancreatitis and pancreatic cancer. Pancreatology 5(4-5), 361-369 (2005
12. Ammirante M, Rosati A, Arra C et al. IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth. Proc. Natl Acad. Sci. USA 107(16), 7497-7502 (2010
13. Zitvogel L, Kroemer G. The dilemma of anticancer therapy: tumor-specific versus immune effects. Blood 112(12), 4364-4365 (2008
14. Yamamoto M, Taguchi Y, Ito-Kureha T, Semba K, Yamaguchi N, Inoue J. NF-kappaB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype. Nat. Commun. 4, 2299 (2013
15. Ferris RL, Grandis JR. NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma. Clin. Cancer Res. 13(19), 5663-5664 (2007
16. Belayev L, Bar-Joseph A, Adamchik J, Biegon A. HU-211, a nonpsychotropic cannabinoid, improves neurological signs and reduces brain damage after severe forebrain ischemia in rats. Mol. Chem. Neuropathol. 25(1), 19-33 (1995
17. Oesch S, Walter D, Wachtel M et al. Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma. Mol. Cancer Ther. 8(7), 1838-1845 (2009
18. McKallip RJ, Lombard C, Fisher M et al. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 100(2), 627-634 (2002
19. Hart S, Fischer OM, Ullrich A. Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res. 64(6), 1943-1950 (2004
20. Juttler E, Potrovita I, Tarabin V et al. The cannabinoid dexanabinol is an inhibitor of the nuclear factor-kappa B (NF-kappa B). Neuropharmacology 47(4), 580-592 (2004).